| Short Description : | MAP3K10 Blocking Peptide for STJ501665 is synthetically produced from the 900-950 sequence and is suitable for use in western blot applications. |
| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | MAP3K10 |
| Gene ID: | 4294 |
| Uniprot ID: | M3K10_HUMAN |
| Immunogen: | Synthetic peptide correpsonding to the C-terminal taken within amino acid region 900-950 on human MAP3K10 protein. |
| Immunogen Region: | 900-950 |
| Specificity: | This blocking peptide is recommended for use in combination with MAP3K10 antibody, STJ501665 |
| Tissue Specificity | Expressed in brain and skeletal muscle. |
| Post Translational Modifications | Autophosphorylation on serine and threonine residues within the activation loop plays a role in enzyme activation. |
| Function | Activates the JUN N-terminal pathway. |
| Peptide Name | Mitogen-Activated Protein Kinase Kinase Kinase 10Mixed Lineage Kinase 2Protein Kinase Mst |
| Alternative Peptide Names | Mitogen-Activated Protein Kinase Kinase Kinase 10 proteinMixed Lineage Kinase 2 proteinProtein Kinase Mst proteinMAP3K10 proteinMLK2 proteinMST protein |
Information sourced from Uniprot.org